Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New hope for young leukemia patients?

17.11.2011
Researchers have identified a potential marker for leukemic relapse

The development of simple tests to predict a leukemic relapse in young patients is a step closer thanks to researchers from the Sainte-Justine University Hospital Research Center and the University of Montreal. Approximately 20 percent of young leukemia patients who are treated with stem cells derived from umbilical cord blood will experience leukemic relapse. The researchers' findings, published recently in Blood, demonstrate that the blame falls partially on a subset of white blood cells called "T cells." Until now, this process had been poorly understood.

"We have shown that a particular marker on the T-cells, PD-1, was found significantly more frequently in those young patients in whom relapses were about to occur," says lead author, Dr. Hugo Soudeyns, an investigator at the Sainte-Justine University Hospital Research Center, affiliated with Université de Montreal. "PD-1 is also an indicator of 'T cell exhaustion', a process whereby T cells lose their capacity to multiply and are less effective at fighting viruses and cancer cells."

Window of vulnerability

Dr. Soudeyns and his colleagues analyzed blood samples from young children who received an umbilical cord blood transplant for the treatment of blood disorders, including leukemia. They were particularly interested in studying the three to six month time period post-transplantation, when the children were most susceptible to both relapse and infection. During this time, expression of the PD-1 marker peaked, suggesting that many of these T cells were at the end of their life cycle and thus less effective.

"Our findings suggest that measurement of exhaustion markers such as PD-1 could serve as an early predictor of leukemic relapse – a very serious complication," says Dr. Soudeyns. "Our next step is to repeat these experiments in larger groups of patients."

The input of the ELISpot reader

Thanks to the financial support of the Fondation Centre de cancérologie Charles-Bruneau, Dr Soudeyns' team was able to count on a new ELISpot reader, which analyzes the reaction of cells to stimulus. This reader played an important part in the study of blood samples selected for this test. The Fondation is proud of its positive contribution to this research and congratulates Dr Soudeyns for this remarquable scientific breakthrough.

Leukemia and stem cell transplants

Leukemia is a type of blood cancer. Children with leukemia are frequently treated with chemotherapy and radiation to eradicate the cancer cells, but this treatment also leads to the destruction of both their red and white blood cells. To replenish these cells, leukemic children often undergo a bone marrow transplant. Another similar procedure involves transplantation of umbilical cord blood instead of bone marrow.

Study Details

The study, led by Dr. Hugo Soudeyns, an investigator in the Viral and Immune Disorders and Cancers research axis at the Sainte-Justine University Hospital Research Center and the Departments of Microbiology & Immunology and Pediatrics at Université de Montréal, was published online on August 2, 2011 in the scientific journal Blood. Dr. Natacha Merindol is first author, followed by Dr. Martin A. Champagne and Dr. Michel Duval. The study was published in the October 26, 2011 issue of Blood and was highlighted in an editorial that underscored the originality of the work.

The study was funded by le Fonds de recherche en santé du Québec (FRSQ), Héma-Québec, la Fondation Centre de cancérologie Charles-Bruneau, the Cole Foundation, and la Fondation de l'Hôpital Sainte-Justine.

William Raillant-Clark | EurekAlert!
Further information:
http://www.umontreal.ca

More articles from Health and Medicine:

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>